Advertisement
Screener

CRONOS GROUP INC. (CRON) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Comprehensive Income

CRONOS GROUP INC. (CRON) reported Comprehensive Income of $10.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06

  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $10.28M, a 43.92% decline year-over-year.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$3.32M, a 203.94% decline year-over-year.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $15.02M.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $687.00K, a 96.57% decline year-over-year.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $37.24M.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$43.12M.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$52.49M.
  • CRONOS GROUP INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$219.40M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filedComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2026-06-30$10.28M
10-Q · filed 2026-08-06
$6.96M
10-Q · filed 2026-08-06
$21.98M
derived: sum of 3 quarters · filed 2026-08-06
$22.66M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$3.32M
10-Q · filed 2026-05-11
$11.69M
derived: sum of 2 quarters · filed 2026-05-11
$12.38M
derived: sum of 3 quarters · filed 2026-05-11
$30.71M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$15.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$15.70M
derived: sum of 2 quarters · filed 2026-02-26
$34.04M
derived: sum of 3 quarters · filed 2026-08-06
$37.24M
10-K · filed 2026-02-26
2025-09-30$687.00K
10-Q · filed 2025-11-06
$19.02M
derived: sum of 2 quarters · filed 2026-08-06
$22.22M
10-Q · filed 2025-11-06
$2.78M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$18.33M
10-Q · filed 2026-08-06
$21.53M
10-Q · filed 2026-08-06
$2.10M
derived: sum of 3 quarters · filed 2026-08-06
$22.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$3.20M
10-Q · filed 2026-05-11
-$16.24M
derived: sum of 2 quarters · filed 2026-05-11
$3.76M
derived: sum of 3 quarters · filed 2026-05-11
-$15.21M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$19.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$566.00K
derived: sum of 2 quarters · filed 2026-02-26
-$18.41M
derived: sum of 3 quarters · filed 2026-02-26
-$43.12M
10-K · filed 2026-02-26
2024-09-30$20.00M
10-Q · filed 2025-11-06
$1.02M
derived: sum of 2 quarters · filed 2025-11-06
-$23.69M
10-Q · filed 2025-11-06
-$45.69M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$18.98M
10-Q · filed 2025-08-07
-$43.69M
10-Q · filed 2025-08-07
-$65.69M
derived: sum of 3 quarters · filed 2026-02-26
-$87.51M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$24.71M
10-Q · filed 2025-05-08
-$46.71M
derived: sum of 2 quarters · filed 2026-02-26
-$68.53M
derived: sum of 3 quarters · filed 2026-02-26
-$60.37M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$43.82M
derived: sum of 2 quarters · filed 2026-02-26
-$35.65M
derived: sum of 3 quarters · filed 2026-02-26
-$52.49M
10-K · filed 2026-02-26
2023-09-30-$21.82M
10-Q · filed 2024-11-12
-$13.65M
derived: sum of 2 quarters · filed 2024-11-12
-$30.49M
10-Q · filed 2024-11-12
-$91.19M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$8.17M
10-Q · filed 2024-08-08
-$8.66M
10-Q · filed 2024-08-08
-$69.37M
derived: sum of 3 quarters · filed 2025-02-27
-$167.03M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$16.84M
10-Q · filed 2024-05-09
-$77.54M
derived: sum of 2 quarters · filed 2025-02-27
-$175.19M
derived: sum of 3 quarters · filed 2025-02-27
-$219.82M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$60.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$158.36M
derived: sum of 2 quarters · filed 2025-02-27
-$202.98M
derived: sum of 3 quarters · filed 2025-02-27
-$219.40M
10-K · filed 2025-02-27
2022-09-30-$97.66M
10-Q · filed 2023-11-08
-$142.28M
derived: sum of 2 quarters · filed 2023-11-08
-$158.69M
10-Q · filed 2023-11-08
-$291.39M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$44.62M
10-Q · filed 2023-08-08
-$61.04M
10-Q · filed 2023-08-08
-$193.73M
derived: sum of 3 quarters · filed 2024-02-29
-$138.62M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$16.41M
10-Q · filed 2023-05-09
-$149.11M
derived: sum of 2 quarters · filed 2024-02-29
-$94.00M
derived: sum of 3 quarters · filed 2024-02-29
-$259.49M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$132.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$77.58M
derived: sum of 2 quarters · filed 2024-02-29
-$243.07M
derived: sum of 3 quarters · filed 2024-02-29
-$389.24M
10-K · filed 2024-02-29
2021-09-30$55.11M
10-Q · filed 2022-11-07
-$110.38M
derived: sum of 2 quarters · filed 2022-11-07
-$256.54M
10-Q · filed 2022-11-07
-$316.96M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$165.49M
10-Q · filed 2022-08-09
$70.64M
10-Q · filed 2021-08-06
-$311.66M
10-Q · filed 2022-08-09
-$75.53M
10-Q · filed 2021-08-06
-$372.07M
derived: sum of 3 quarters · filed 2023-02-28
-$276.89M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$146.17M
10-Q · filed 2022-05-10
-$206.58M
derived: sum of 2 quarters · filed 2023-02-28
-$111.40M
derived: sum of 3 quarters · filed 2023-02-28
-$166.47M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$60.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$34.77M
derived: sum of 2 quarters · filed 2023-02-28
-$20.30M
derived: sum of 3 quarters · filed 2023-02-28
-$57.98M
10-K · filed 2023-02-28
2020-09-30$95.18M
10-Q · filed 2022-02-18
$40.11M
derived: sum of 2 quarters · filed 2022-02-18
$2.44M
10-Q · filed 2022-02-18
$92.72M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$55.07M
10-Q/A · filed 2022-02-18
-$92.75M
10-Q/A · filed 2022-02-18
-$2.46M
derived: sum of 3 quarters · filed 2022-03-01
$589.54M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$37.67M
10-Q · filed 2021-05-07
$52.61M
derived: sum of 2 quarters · filed 2022-03-01
$644.61M
derived: sum of 3 quarters · filed 2022-03-01
$848.55M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$90.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$682.28M
derived: sum of 2 quarters · filed 2022-03-01
$886.23M
derived: sum of 3 quarters · filed 2022-03-01
$1.20B
10-K · filed 2022-03-01
2019-09-30$592.00M
10-Q · filed 2020-11-05
$795.94M
derived: sum of 2 quarters · filed 2020-11-05
$1.11B
10-Q · filed 2020-11-05
2019-06-30$203.95M
10-Q · filed 2020-08-06
$521.93M
10-Q · filed 2020-08-06
2019-03-31$317.99M
10-Q · filed 2020-05-08
2018-12-31-$33.96M
10-K · filed 2021-02-26
2017-12-31$1.38M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87